Molecular imaging developer Sofie Biosciences and life sciences firm PerkinElmer have inked a multiyear extension of their existing partnership to develop preclinical in vivo imaging tools for PET.
The new deal will expand technology development to include new proprietary detectors and will also further increase manufacturing scale, according to the firms.
In other Sofie news, the company has raised $3.7 million in a financing round that was oversubscribed by nearly $1 million. Sofie said it plans to use the funds to target unmet clinical needs with new generations of imaging agents and scanners.
